Skip to main content

A Prospective, Multicenter, Long-Term Study to Assess the Safety and Efficacy of Nemolizumab (CD14152) in Subjects with Moderate-to-Severe Atopic Dermatitis

Clinical Trial Grant
Duke Scholars

Administered By

Dermatology

Awarded By

Galderma

Start Date

June 18, 2020

End Date

February 10, 2022
 

Administered By

Dermatology

Awarded By

Galderma

Start Date

June 18, 2020

End Date

February 10, 2022